Evidence map›Paper›PMID 18191243›Full record

ArticleInternational journal of cardiology2008

Extracardiac features predicting 22q11.2 deletion syndrome in adult congenital heart disease.

Wai Lun Alan Fung, Eva W C Chow, Gary D Webb, Michael A Gatzoulis, Anne S Bassett

Open access · greenAbstract readComparative Study
In one paragraph

Article in International journal of cardiology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. 1q21.1 Microduplication expression in adults.Genetics in medicine : official journal of the American College of Medical Genetics · 2013
    Pooled it
  2. Article
  3. NPJ genomic medicine · 2016
    Article
  4. Article
  5. Response to clozapine in a clinically identifiable subtype of schizophrenia.The British journal of psychiatry : the journal of mental science · 2015
    Observational
  6. Delineating the 15q13.3 microdeletion phenotype: a case series and comprehensive review of the literature.Genetics in medicine : official journal of the American College of Medical Genetics · 2015
    Review
  7. 22q11 deletion syndrome: current perspective.The application of clinical genetics · 2015
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Functional outcomes of adults with 22q11.2 deletion syndrome.Genetics in medicine : official journal of the American College of Medical Genetics · 2012
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

Wai Lun Alan FungClinical Genetics Research Program, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
Eva W C Chow
Gary D Webb
Michael A Gatzoulis
Anne S Bassett
University Health Network · CAAdult Congenital Heart Association · USCentre for Addiction and Mental Health · CAUniversity of Toronto · CA

Funding

CIHR 79518
6 · The paper itself

Abstract

BACKGROUND AND

objectives22q11.2 Deletion Syndrome (22q11.2DS) is an important genetic syndrome to cardiologists yet remains under-recognized in adults. There is no evidence-based guideline for genetic testing referrals. Feasibility issues in many jurisdictions preclude testing for 22q11.2 deletions in every congenital cardiac patient. We aimed to determine an optimal combination of extracardiac features that could be clinically helpful in identifying adults with tetralogy of Fallot (TOF) and related conotruncal anomalies at highest risk for 22q11.2DS.

methodsAdults (n=103) at a congenital cardiac clinic (86 with TOF) had a brief clinical screening assessment and genetic testing for 22q11.2 deletions using standard fluorescence in-situ hybridization; 31 had a 22q11.2 deletion. Discriminant ability (DA), defined as (sensitivity+specificity)/2, was used to measure performance of 18 (17 clinical and one demographic) features in predicting 22q11.2DS (DA>80%=a good screening test).

resultsCombining two features was required for a good test: a global impression of 22q11.2DS dysmorphic facies, with either learning difficulties (DA=82.4%) or voice abnormalities such as hypernasality (DA=81.6%). A four-feature combination (suggestive dysmorphic facies, voice abnormalities, learning difficulties and age <30 years) yielded maximal sensitivity (100%) and DA>85% at a cut-off of three features. Neither rates of right aortic arch or cardiac surgery differed between patients with and without 22q11.2 deletions.

conclusionsClinicians who consider as few as two extracardiac features readily detectable in a brief clinical encounter could help identify those with 22q11.2DS among adults with congenital heart disease. Diagnosis of 22q11.2DS is important for optimizing management of these complex patients.

Indexed as

AdolescentAdultAge FactorsCraniofacial AbnormalitiesDiGeorge SyndromeFemaleGenetic TestingHeart Defects, CongenitalHumansMaleMiddle AgedPredictive Value of TestsYoung Adult

Identifiers

PMID18191243
PMCPMC3139626
OpenAlexW2094281807

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.